Zimbabwe has declined a major American health deal valued at 367 million US dollars (272 million pounds) over five years due to the United States' demand for sensitive biological samples.
This move came to light following a official document dated December was disclosed, revealing that President Emmerson Mnangagwa felt the arrangement was "unbalanced".
An official spokesperson has since explained that the US was demanding access to health data for research and commercial gain while was not willing to guarantee the resulting advantages from any future vaccines.
"We will now turn to the difficult and regrettable process of scaling back our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the United States had provided over $1.9bn in health funding to Zimbabwe during the past two decades.
A medical body in Zimbabwe has appealed for continued negotiations to reach a deal agreeable to all parties so the nation's critical HIV treatment initiative can be sustained.
Broader Background
This rejection follows a comparable situation in Kenya, where a court blocked a similar deal with the US following legal challenges were raised about the security of citizens' health data.
Since returning to office recently, US President Donald Trump has reduced foreign aid and closed the US Agency for International Development (USAID).
The agency had managed aid for the American government, but Trump claimed its spending was "inefficient" and his administration was seeking direct bilateral agreements to boost openness and accountability.
Based on reports, Sixteen nations in Africa have so far signed similar agreements, representing over $18.3bn in committed funds.
Specifics of the Declined Agreement
This assistance for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this collaboration would have delivered immense advantages for the people of Zimbabwe, especially the 1.2 million currently on HIV treatment through US-supported initiatives," the Ambassador added.
However, government spokesperson Nick Mangwana said the arrangement was "unfair".
"Our nation was requested to surrender its biological resources and data indefinitely, with no equivalent promise of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that might result from that provided information," he stated.
"In essence, our country would supply the raw materials for scientific discovery with no certainty that the resulting innovations would be available to our citizens should a new health crisis arise."
Sovereignty and Global Health
He also noted that the US's withdrawal from the global health body and its push of one-on-one deals were undermining systems previously set up through the global health agency.
Mangwana cited its Pandemic Benefit-Sharing system designed to deal with future pandemics.
"This mechanism is designed to ensure that when a nation provides its data, the resulting advantages – such as vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the funds to create them."
Zimbabwe's reservations regarding the US deal "must not be interpreted as hostility towards the US," he added.
"We welcome further discussions with our US partners on how future co-operation could be arranged in a way that honours the sovereignty and dignity of both nations."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it recognised the official position, but recommended that negotiations need to persist given that a large portion of the country's Aids initiatives were funded by international support.
"Where technical issues exist, such as those relating to information security or implementation frameworks, these can often be resolved via technical clarification and negotiated safeguards," it commented.
The halted deal underscores the continuing debate between accepting vital foreign assistance and protecting local interests in an ever more interconnected world.